Researcher
Thierry VandenDriessche
- Keywords (Vrije Universiteit Brussel):Medicine, Applied biological sciences, biotechnology
- Disciplines (Vrije Universiteit Brussel):Hematology, Neurological and neuromuscular diseases, Cancer therapy, Cardiology, Computational transcriptomics and epigenomics
- Disciplines (KU Leuven):Gene and molecular therapy
- See also: Thierry Vandendriessche (KU Leuven)
Affiliations
- Division of Gene Therapy & Regenerative Medicine (Research group)
Responsible
From19 Apr 2011 → Today - Basic (bio-) Medical Sciences (Department)
Member
From8 Apr 2019 → Today - Basic (bio-) Medical Sciences (Department)
Member
From1 Jan 2014 → 20 Oct 2022 - Cell Biology and Histology (Department)
Member
From1 Oct 2010 → 31 Dec 2013 - Department of Bio-engineering Sciences (Department)
Member
From1 Feb 2010 → 28 Feb 2010 - Immunology and Microbiology (Department)
Member
From1 Oct 2007 → 30 Sep 2010 - Department of Bio-engineering Sciences (Department)
Member
From1 Feb 2007 → 30 Sep 2010 - Department of Bio-engineering Sciences (Department)
Member
From1 Oct 2003 → 30 Sep 2004 - Centre for Molecular and Vascular Biology (Division)
Member
From1 Oct 1999 → Today - Department of General Biology (Research group)
Member
From1 Oct 1990 → 30 Sep 1994
Projects
1 - 10 of 17
- HERCULES: DEVELOPMENT OF NEXT-GENERATION GENE THERAPY TO TREAT GENETIC MUSCLE DISORDERSFrom1 Mar 2024 → TodayFunding: BOF - Methusalem
- HERCULES: Development of an innovative muscle-directed gene therapy platform for lysosomal storage disordersFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- SRP-Groeifinanciering: “RESTORE”: DEVELOPMENT OF INNOVATIVE GENE THERAPIES FOR GENETIC MUSCLE DISORDERSFrom1 Oct 2022 → TodayFunding: BOF - projects
- TREAT-SARCO: Development of a novel gene therapy strategy for sarcoglycan deficiencyFrom1 Jan 2020 → 31 Dec 2023Funding: FWO research project (including WEAVE projects)
- UPGRADE: Unlocking Precision Gene TherapyFrom1 Jan 2019 → TodayFunding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- UPGRADE: Unlocking Precision Gene Therapy (OZR EU Bonus)From1 Jan 2019 → 31 Dec 2023Funding: BOF - Other initiatives
- GENEFIX: Development of muscle-targeted gene therapy for hemophilia B using longer-acting clotting factor IXFrom1 Jan 2016 → 31 Dec 2019Funding: FWO research project (including WEAVE projects)
- Advanced T-cell Therapy for Augmented Cancer Killing ("ATTACK"): next-generation T-cell immunotherapy directed against lymphoid malignanciesFrom1 Jan 2016 → 31 Dec 2019Funding: FWO research project (including WEAVE projects)
- Financing IOF-program GEAR: Hyperactieve Expressie-modulesFrom1 Apr 2014 → 31 Mar 2020Funding: IOF - Industrial Research Fund
- SRP (Groeiers): Next-generation gene therapy by computational vector design and immune stealth nanotechnologyFrom1 Mar 2014 → 28 Feb 2019Funding: BOF - Concerted Research Project from 1994
Publications
31 - 40 of 70
- Gene therapy for cardiovascular disease(2015)
Authors: Melvin Y Rincon, Thierry VandenDriessche, Marinee K Chuah
Pages: 4-20 - Percutaneous occlusion of post-myocardial infarction ventricular septum rupture(2014)
Authors: F. Risseeuw, I. Diebels, Thierry Vandendriessche, I. E. Rodrigus
Pages: 47-51 - Vector decoys trick the immune response.(2013)
Authors: Thierry VandenDriessche, Marinee K Chuah
Pages: 28-28 - Targeting endothelial cells by gene therapy.(2013)
Authors: Thierry VandenDriessche, Marinee K Chuah
Pages: 1993-1994 - Glioblastoma: bridging the gap with gene therapy.(2013)
Authors: Thierry VandenDriessche, Marinee K Chuah
Pages: 789-790 - Low hippocampal PI(4,5)P2 contributes to reduced cognition in old mice as a result of loss of MARCKS.(2013)
Authors: L. Trovò, T. Ahmed, Z. Callaerts-Vegh, A. Buzzi, C. Bagni, Marinee K Chuah, Thierry VandenDriessche, R. D'hooge, D. Balschun, C.g. Dotti
Pages: 449-455 - Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases(2013)
Authors: Jp Tremblay, X. Xiao, A. Aartsma-Rus, C. Barbas, H.m. Blau, A.j. Bogdanove, K. Boycott, S. Braun, Xo Breakefield, J.a. Bueren, et al.
Pages: 266-268 - Platelet-directed gene therapy overcomes inhibitory antibodies to factor VIII.(2012)
Authors: Marinee K Chuah, Thierry VandenDriessche
Pages: 1566-1569 - Thrombospondin-2 prevents cardiac injury and dysfunction in viral myocarditis through the activation of regulatory T-cells.(2012)
Authors: A. Papageorgiou, M. Swinnen, D. Vanhoutte, Thierry VandenDriessche, Marinee K Chuah, A. Lindner, W. Verhesen, E. De Vries, J. D'hooge, E. Lutgens, et al.
Pages: 115-124 - Detection of Pseudomonas aeruginosa in sputum headspace through volatile organic compound analysis.(2012)
Authors: P. Goeminne, Thierry VandenDriessche, J. Van Eldere, B. Nicolai, M. Hertog, Lj Dupont
Pages: 87-87
Patents
1 - 10 of 10
- Muscle-specific nucleic acid regulatory elements and methods and use thereof (Inventor)
- Vectors for liver-directed gene therapy of hemophilia and methods and use thereof (Inventor)
- Optimized liver-specific expression systems for fviii and fix (Inventor)
- Novel combination of nucleic acid regulatory elements and methods and uses thereof (Inventor)
- Novel combination of nucleic acid regulatory elements and methods and uses thereof (Inventor)
- Muscle-specific nucleic acid regulatory elements and methods and use thereof (Inventor)
- Vectors for liver-directed gene therapy of hemophilia and methods and use thereof (Inventor)
- Vector for liver-directed gene therapy of hemophilia and methods and use thereof (Inventor)
- Cardiomyocyte-derived nucleic acid regulatory elements and methods and use thereof (Inventor)
- Vector for liver-directed gene therapy of hemophilia and methods and use thereof (Inventor)